Wolverine: Research Overview and Mechanism

Wolverine is a research blend that combines two peptides, BPC-157 and TB-500, in one lyophilized vial. Because it contains more than one molecule, it does not have a single molecular formula, CAS number, or molecular weight; the identity and quantity of each component are documented on the accompanying Certificate of Analysis.

The blend is intended as a convenience for research protocols that study both peptides together, rather than reconstituting each separately.

The two components are studied across complementary tissue-repair pathways. BPC-157 is studied in preclinical models for angiogenesis and cytoprotection, while TB-500, a synthetic fragment of thymosin beta-4, is studied for cell migration and actin regulation, where the parent thymosin beta-4 is known in the literature to sequester monomeric G-actin and influence cytoskeletal reorganization. Combining the two in one vial lets a single research protocol probe both pathway sets. These pathway descriptions are research findings about each molecule, not human outcomes for the blend.

Wolverine is supplied as a 20mg two-peptide lyophilized blend, so it deliberately carries no single molecular formula, CAS number, or molecular weight; those single-molecule fields read as blend on the specification because two distinct peptides share the vial. The lot-matched Certificate of Analysis is therefore the authoritative record of which peptides are present and in what documented ratio. Store the powder at -20C protected from light and reconstitute with bacteriostatic water, swirling gently rather than shaking.